asfotase alfa
Generic: asfotase alfa·Brand: Strensiq
asfotase alfa: 1 clinical trial tracked.
asfotase alfa evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about asfotase alfa, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safety and Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric Participants (2 to < 12 Years of Age) With Hypophosphatasia (HPP) Previously Treated With Asfotase Alfa
Primary endpoint: Number of Participants with Treatment-emergent Adverse Events (TEAEs)
InterventionalRandomizedopen43 targetStarted 2024-04Completion 2028-0221 sites · Argentina, Australia, Canada, Japan…Alexion Pharmaceuticals, Inc.